Financhill
Buy
68

NRIX Quote, Financials, Valuation and Earnings

Last price:
$19.01
Seasonality move :
-7.66%
Day range:
$18.78 - $19.47
52-week range:
$8.18 - $22.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
18.75x
P/B ratio:
3.93x
Volume:
1.1M
Avg. volume:
1.9M
1-year change:
2.04%
Market cap:
$1.5B
Revenue:
$54.5M
EPS (TTM):
-$2.97

Earnings Data

Next earnings date for NRIX
Jan 28
2026
Most recent earnings per share
-$1.03
Missed by $0.18
(Oct 9/2025)
Consensus Estimate
-$0.85
(Oct 9/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NRIX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2026 Q1 $16.7M -- -- -$0.83 --
01/28/2026 Q4 $13.4M -- -- -$0.92 --
10/09/2025 Q3 $16.1M $7.9M -$1.03 -$0.85 -$0.18
07/10/2025 Q2 $17.5M $44.1M -$0.52 -$0.74 $0.23
04/08/2025 Q1 $13M $18.5M -$0.67 -$0.76 $0.09
01/28/2025 Q4 $12.9M $13.3M -$0.75 -$0.67 -$0.08
10/11/2024 Q3 $12.3M $12.6M -$0.67 -$0.68 $0.01
07/11/2024 Q2 $21.8M $12.1M -$0.71 -$0.63 -$0.08
04/10/2024 Q1 $17.1M $16.6M -$0.76 -$0.79 $0.03
02/15/2024 Q4 $34.1M $15.2M -$0.77 -$0.50 -$0.27
10/12/2023 Q3 -- $18.5M -$0.68 -- --
07/13/2023 Q2 -- $30.7M -$0.45 -- --
04/13/2023 Q1 -- $12.7M -$0.75 -- --
02/09/2023 Q4 -- $6.8M -$0.87 -- --
10/06/2022 Q3 -- $10.8M -$0.90 -- --
07/07/2022 Q2 -- $11.4M -$1.01 -- --
04/08/2022 Q1 -- $9.6M -$0.95 -- --
01/27/2022 Q4 -- $7.4M -$0.85 -- --
10/14/2021 Q3 -- $10.3M -$0.65 -- --
07/13/2021 Q2 -- $7.1M -$0.60 -- --
04/13/2021 Q1 -- $5M -$0.63 -- --
02/16/2021 Q4 -- $6.7M -$0.51 -- --
10/14/2020 Q3 -- $4.1M -$1.77 -- --
05/31/2020 Q2 -- $4.2M $0.20 -- --
02/29/2020 Q1 -- $2.9M -$0.96 -- --
11/30/2019 Q4 -- $1.9M -$0.35 -- --
08/31/2019 Q3 -- $10.6M -$0.22 -- --
05/31/2019 Q2 -- $9.4M -$0.08 -- --
02/28/2019 Q1 -- $9.2M -$0.21 -- --

Nurix Therapeutics, Inc. Earnings Questions

  • How Much did Nurix Therapeutics, Inc. Generate in Revenue Last Quarter?

    Nurix Therapeutics, Inc. reported $7.9M worth of top line sales in its most recent quarter.

  • Did Nurix Therapeutics, Inc. Beat Earnings Last Quarter?

    Nurix Therapeutics, Inc. announced earnings per share of -$1.03 which represents a miss of analyst forecast a -$0.85 per share.

  • Is Nurix Therapeutics, Inc. Profitable?

    Nurix Therapeutics, Inc. reported $2.9M that represents $0.03 per share over the last quarter.

  • What is the Analyst Consensus for Nurix Therapeutics, Inc. EPS Next Year?

    Nurix Therapeutics, Inc.'s earnings are forecast to decrease from -$2.88 per share to -$3.10 per share next year representing a decrease of -18.32%.

  • When is Nurix Therapeutics, Inc.'s Earnings Date?

    Nurix Therapeutics, Inc.'s next earnings date is January 28, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
3
SMX alert for Dec 31

SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.

Buy
80
FTAI alert for Dec 31

FTAI Aviation Ltd. [FTAI] is up 14.37% over the past day.

Sell
45
LYEL alert for Dec 31

Lyell Immunopharma, Inc. [LYEL] is down 12.45% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock